GVR Report cover Single Nucleotide Polymorphisms Genotyping Market Size, Share & Trends Report

Single Nucleotide Polymorphisms Genotyping Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

  • Report ID: 628
  • Number of Pages: 0
  • Format: Electronic (PDF)

The global single nucleotide polymorphisms genotyping market is expected to witness significant growth over the forecast period. Single Nucleotide Polymorphisms (SNP) genotyping is the process of analyzing and screening of genetic variations of SNPs between members of a species. It is an upcoming area of interest for researchers for genomics and life science studies. SNP genotyping has a broad range of applications in a number of industries such as pharmaceuticals, research, agricultural biotechnological, and others which leads to change in dairy and meat yield and crop yields. The use of SNP genotyping is growing rapidly from personalized genetic testing to plant and animal biotechnology. SNP genotyping gives an idea about the human genome characterization and transfer of hereditary diseases. SNP genotyping is of great value for the pharmaceutical and medical fields as it predicts disease association and the response of an individual for a specific medication. Human SNP genotyping has lots of implications in diseases prognosis and treatment, clinical diagnostics, in new drug discovery, and improving the current practice of medicine.

Some of the other driving factors for this market are growing prevalence of fatal diseases such as cancer, diabetes, and others, increasing demand for genetic analysis in animal and plant feedstock, the presence of private and public funding programs in the field of genetics. On the basis of product, single nucleotide polymorphisms genotyping market is segmented into consumables or reagent, instruments, and services. Introduction of technological advancements on the grounds of accuracy, portability, and cost-effectiveness such as growing use of real time and multiplex PCR and massarrays system is expected to drive the market at a rapid pace. On the basis of application, the market is segmented into pharmacogenomics & pharmaceuticals, diagnostic research, breeding & animal livestock, and agricultural biotechnology. On the basis of technology, the SNP genotyping market is classified into taqman allelic discrimination, microarrays & SNP genechips, Sequenom Massarray, MALDI-TOF, applied biosciences SNPlex, SNP pyrosequencing, and other SNP genotyping technologies. Taqman allelic discrimination is the process of identifying one and only one gene or allele with the use of DNA polymerase and ligase enzyme. Sequenom’s massarray system determines SNP by detecting molecular weight of DNA fragments.

Globally single nucleotide polymorphisms (SNP) genotyping market is segmented into four major regions such as Europe, North America, Asia Pacific, and RoW. North America is considered as the most dominant market due to favorable government policies towards proper diagnosis, screening and treatment of fatal diseases, availability of better R&D facilities, and the presence of advanced technologies. Europe and Asia Pacific market are emerging owing to the development of various plans and policies of the government, rising incidences of targeted diseases, improvements in healthcare services, increasing demand for personalized medicines, and rising economic development. Key players in this market area are, Sequenom, Inc., Douglas Scientific LLC, PREMIER Biosoft, Sequenom Inc., Luminex Corp., Life Technologies Corp., Fluidigm, Illumina, Inc., Affymetrix, Inc.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.